GH Secretagogue Research Stack · COA Verified
For research and laboratory use only. Not for human consumption. By purchasing, you confirm you are a qualified researcher.
For Research Purposes Only. Not approved for human consumption.
The CJC-1295 No DAC / Ipamorelin Blend combines two complementary growth hormone secretagogues into a single, precisely formulated research compound. CJC-1295 No DAC (Mod GRF 1-29) acts on the GHRH receptor to amplify pulsatile GH release; Ipamorelin selectively targets the ghrelin receptor (GHS-R1a) to stimulate GH secretion with minimal cortisol or prolactin impact. Together they engage dual GH-release pathways, making this combination one of the most-studied GH secretagogue stacks in preclinical research.
Q: Why combine CJC-1295 No DAC and Ipamorelin?
A: They work through different receptor pathways — CJC-1295 No DAC activates GHRH receptors; Ipamorelin activates GHS-R1a (ghrelin receptors). Research shows these pathways are synergistic, producing greater GH pulse amplitude than either compound alone.
Q: What is CJC-1295 No DAC?
A: Also called Mod GRF 1-29, this is a truncated, stabilized GHRH analog without the Drug Affinity Complex (DAC) modification. It produces short, pulsatile GH release that mimics natural GH secretion patterns.
Q: What is Ipamorelin?
A: A selective growth hormone releasing peptide (GHRP) that stimulates GH secretion with high selectivity and minimal effect on cortisol or prolactin.
Q: Are both peptides in the same vial?
A: Yes. This is a co-lyophilized blend with both compounds at equal proportions per the selected dose variant.
Related Research: CJC-1295 No DAC Standalone | Ipamorelin Standalone
For laboratory research use only. Not for human consumption. Not evaluated by the FDA.
